These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15687731)

  • 1. First trimester screening.
    Ellestad SC; Wells SR; Kuller JA
    Gynecol Obstet Invest; 2005; 60(1):58-62. PubMed ID: 15687731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aneuploidy screening: what test should I use?
    Berkowitz RL; Cuckle HS; Wapner R; D'Alton ME
    Obstet Gynecol; 2006 Mar; 107(3):715-8. PubMed ID: 16507946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of second-trimester serum screening in the post-first-trimester screening era.
    Shamshirsaz AA; Benn P; Egan JF
    Clin Lab Med; 2010 Sep; 30(3):667-76. PubMed ID: 20638580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood.
    Sekizawa A; Purwosunu Y; Matsuoka R; Koide K; Okazaki S; Farina A; Saito H; Okai T
    J Obstet Gynaecol Res; 2007 Dec; 33(6):747-64. PubMed ID: 18001438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in antenatal screening for Down syndrome.
    Wald NJ; Hackshaw AK
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Aug; 14(4):563-80. PubMed ID: 10985931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening for Down syndrome.
    Ogle RF; Chitty LS
    Hosp Med; 1998 Aug; 59(8):632-6. PubMed ID: 9829057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACOG Committee Opinion #296: first-trimester screening for fetal aneuploidy.
    Obstet Gynecol; 2004 Jul; 104(1):215-7. PubMed ID: 15229041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New frontiers in noninvasive, prenatal screening and diagnosis: fetal DNA circulating in maternal blood].
    Montagnana M; Lippi G; Guidi GC
    Minerva Ginecol; 2007 Jun; 59(3):331-41. PubMed ID: 17576408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester screening for chromosomal abnormalities: advantages of an instant results approach.
    Norton ME
    Clin Lab Med; 2010 Sep; 30(3):565-71. PubMed ID: 20638572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive prenatal diagnosis in 2020.
    Lo YM
    Prenat Diagn; 2010 Jul; 30(7):702-3. PubMed ID: 20572103
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prenatal diagnosis].
    Miny P; Tercanli S; Gänshirt D; Holzgreve W
    Ther Umsch; 1995 Dec; 52(12):792-800. PubMed ID: 8539649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of the screening of maternal serum factors for the prenatal diagnosis of fetal developmental defects and chromosomal diseases].
    Arbuzova SB; Nikolenko MI
    Tsitol Genet; 1995; 29(4):44-7. PubMed ID: 8604526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of first-trimester screening for chromosomal abnormalities.
    Bahado-Singh RO; Argoti P
    Clin Lab Med; 2010 Sep; 30(3):545-55. PubMed ID: 20638570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum screening for aneuploidy and open fetal defects.
    Canick JA; Saller DN
    Obstet Gynecol Clin North Am; 1993 Sep; 20(3):443-54. PubMed ID: 8278144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepwise sequential screening for fetal aneuploidy.
    Benn PA; Campbell WA; Zelop CM; Ingardia C; Egan JF
    Am J Obstet Gynecol; 2007 Sep; 197(3):312.e1-5. PubMed ID: 17826434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chorionic villus sampling for abnormal screening compared to historical indications: prevalence of abnormal karyotypes.
    Marshall NE; Fraley G; Feist C; Burns MJ; Pereira L
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1463-6. PubMed ID: 22098166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of prenatal diagnosis: methodological issues and concerns.
    Caughey AB
    Gynecol Obstet Invest; 2005; 60(1):11-8. PubMed ID: 15692215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.
    Wright D; Bradbury I; Benn P; Cuckle H; Ritchie K
    Prenat Diagn; 2004 Oct; 24(10):762-6. PubMed ID: 15503281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Prenatal Risk Calculation (PRC) with PIA Fetal Database software in first-trimester screening for fetal aneuploidy.
    Hörmansdörfer C; Scharf A; Golatta M; Vaske B; Corral A; Hillemanns P; Schmidt P
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):147-51. PubMed ID: 19009535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.